MENU
+Compare
CZMWY
Stock ticker: OTC
AS OF
Oct 7 closing price
Price
$52.55
Change
-$0.95 (-1.78%)
Capitalization
4.62B

CZMWY Carl Zeiss Meditec AG Forecast, Technical & Fundamental Analysis

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery... Show more

CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CZMWY with price predictions
Oct 07, 2025

CZMWY in upward trend: 10-day moving average broke above 50-day moving average on October 06, 2025

The 10-day moving average for CZMWY crossed bullishly above the 50-day moving average on October 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CZMWY just turned positive on October 01, 2025. Looking at past instances where CZMWY's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

CZMWY moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CZMWY advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CZMWY moved out of overbought territory on September 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CZMWY as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZMWY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CZMWY broke above its upper Bollinger Band on September 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CZMWY entered a downward trend on September 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.879) is normal, around the industry mean (10.960). P/E Ratio (26.051) is within average values for comparable stocks, (55.358). Projected Growth (PEG Ratio) (1.213) is also within normal values, averaging (1.743). Dividend Yield (0.012) settles around the average of (0.016) among similar stocks. P/S Ratio (1.789) is also within normal values, averaging (14.464).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CZMWY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZMWY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CZMWY is expected to report earnings to rise 77.94% to 77 cents per share on December 11

Carl Zeiss Meditec AG CZMWY Stock Earnings Reports
Q3'25
Est.
$0.78
Q2'25
Missed
by $0.16
Q1'25
Beat
by $0.15
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of 43 cents, missing the estimate of 59 cents. With 302.00 shares outstanding, the current market capitalization sits at 4.62B.
A.I.Advisor
published Dividends

CZMWY paid dividends on April 15, 2025

Carl Zeiss Meditec AG CZMWY Stock Dividends
А dividend of $0.65 per share was paid with a record date of April 15, 2025, and an ex-dividend date of March 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Goschwitzer Strasse 51-52
Phone
+49 3641220115
Employees
4823
Web
https://www.zeiss.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX63.700.51
+0.81%
American Funds EUPAC R3
MBINX32.280.04
+0.12%
NYLI Balanced Investor Class
TRSSX26.55N/A
N/A
T. Rowe Price Instl Small-Cap Stock
CPEIX26.59N/A
N/A
Catalyst Dynamic Alpha I
VYCIX27.71N/A
N/A
Voya Corporate Leaders 100 W

CZMWY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-1.78%
SMMNY - CZMWY
44%
Loosely correlated
-0.38%
SONVY - CZMWY
38%
Loosely correlated
-0.25%
SAUHY - CZMWY
37%
Loosely correlated
-2.47%
ALGN - CZMWY
37%
Loosely correlated
-0.78%
ALC - CZMWY
36%
Loosely correlated
-1.89%
More

Groups containing CZMWY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
-1.78%
Pharmaceuticals
category (386 stocks)
30%
Poorly correlated
+0.46%
Pharmaceuticals: Other
category (103 stocks)
26%
Poorly correlated
+0.58%